Pozen MT 100 Benefit In Migraine Does Not Outweigh Tardive Dyskinesia Risk

FDA's Peripheral & Central Nervous System Drugs Advisory Committee says additional studies of the naproxen/metoclopramide product must show an effect on two-hour pain-free response.